Interleukin-17 Gene Polymorphisms Contribute to Cancer Risk

Epidemiological studies have suggested that interleukin-17 (IL-17) polymorphisms are associated with cancer risk. However, the results of these studies are inconsistent. Therefore, we performed a meta-analysis to obtain a precise conclusion. Odds ratios (ORs) with 95% confidence intervals (CIs) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Yu-Ming, Yuan, Hua, Zhou, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131465/
https://www.ncbi.nlm.nih.gov/pubmed/25147431
http://dx.doi.org/10.1155/2014/128490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131465/
https://www.ncbi.nlm.nih.gov/pubmed/25147431
http://dx.doi.org/10.1155/2014/128490

Ejemplares similares